Skip to content
Atlas Research Compounds

TA1 vs. Selank

A structured research comparison between Thymosin Alpha 1 and Selank across compound identity, research category, evidence maturity, and interpretation boundaries.

Thymic immune-signaling peptide

Thymosin Alpha 1

Investigated in innate and adaptive immune signaling across preclinical and clinical contexts.

Evidence score4/5

Substantial clinical evidence

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Tuftsin-related neuropeptide

Selank

Investigated in neurochemical, stress-response, and immune-neural signaling models.

Evidence score2/5

Early human evidence

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Side-by-side research context

DimensionThymosin Alpha 1Selank
Catalog identityThymosin Alpha 1 is mapped to thymic immune-signaling peptide research.Selank is mapped to tuftsin-related neuropeptide research.
Research categoryThymosin Alpha 1 is primarily organized around immune modulation and clinical-translational literature.Selank is primarily organized around stress-response and cognition research.
Interpretive boundaryUse the Thymosin Alpha 1 profile and verified study pages before inferring mechanism or outcomes.Use the Selank profile and verified study pages before inferring mechanism or outcomes.

Combined literature starting points

Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.

  1. 01

    Thymosin alpha 1 literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source
  2. 02

    Atlas internal research database

    Internal Research Database · 2026 · Database

    Open source
  3. 03

    Selank literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source